Question 1

What are the potential benefits of adding SBRT to my chemotherapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the mFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma clinical trial (NCT04986930). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this trial compare to other treatment options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the mFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma clinical trial (NCT04986930). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from the treatments in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the mFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma clinical trial (NCT04986930). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatments and tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the mFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma clinical trial (NCT04986930). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience complications during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the mFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma clinical trial (NCT04986930). Contact the study team or your healthcare provider for specific answers.

Question 6

Will my health insurance cover the costs of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the mFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma clinical trial (NCT04986930). Contact the study team or your healthcare provider for specific answers.

What this study is about